PON Antibodies

Santa Cruz Biotechnology features a diverse variety of PON Antibodies for targeting paraoxonase (PON) proteins. PON Antibodies are effective tools in multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Paraoxonases are a family of enzymes that play a crucial role in the metabolism of lipid peroxides and the detoxification of organophosphates, contributing to cardiovascular health and the prevention of oxidative stress. PON proteins have demonstrated significance in studies related to atherosclerosis, neurodegenerative diseases, and other conditions influenced by oxidative damage. Research has shown that paraoxonase enzymes can protect against lipid oxidation and maintain cellular homeostasis. Understanding paraoxonase function has become increasingly important in cardiovascular research and therapeutic development. Recent studies have highlighted the potential of PON proteins as biomarkers for various diseases. The high-quality monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of paraoxonase proteins and their impact on human health.